COMPANY
Perception Neuroscience
Timeline
- Trial start Phase 2: A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05414422 | A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD | Phase 2 | Completed | Feb 1, 2022 | Nov 10, 2022 (actual) |